Edwin Moses
Vorsitzender bei AVANTIUM N.V.
Vermögen: 745 470 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Edwin Moses
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
38
| Subsidiary | Biotechnology | 38 |
Keensight Capital SAS
 Keensight Capital SAS Investment ManagersFinance Keensight Capital SAS (Keensight) is an independent French venture capital firm which was established in 2001. Formerly known as R Capital Management SAS, a subsidiary of the Rothschild Group, the firm became independent in 2013 and changed their name to Keensight Capital. Keensight is located in Paris and manages venture capital investments, including the FCPR R Capital Technologies for a range of clients including European banks, pension schemes, insurance companies, government-controlled entities, fund of funds, family offices and high-net worth private individuals.
27
| Private Company | Investment Managers | 27 |
| Public Company | Industrial Machinery | 19 | |
| Public Company | Pharmaceuticals: Major | 13 | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom.
11
| Public Company | Biotechnology | 11 |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA.
8
| Private Company | Miscellaneous Commercial Services | 8 |
Labgenius Ltd.
 Labgenius Ltd. Pharmaceuticals: MajorHealth Technology Labgenius Ltd. discovers novel and optimized biological molecules using artificial intelligence, automation and synthetic DNA. It specializes in synthetic biology, DNA libraries, protein engineering, artificial intelligence and machine learning. The company was founded by James Field in 2012 and is headquartered in London, the United Kingdom.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK.
6
| Extinct | Pharmaceuticals: Major | 6 |
Galapagos Biotech Ltd.
 Galapagos Biotech Ltd. BiotechnologyHealth Technology Galapagos Biotech Ltd. operates as a drug discovery company which provides discovery technologies and services. Its technologies include Chemogenomics and Silico. The company was founded by Kenneth Leslie Powell and Janet Maureen Thornton in July 8, 1997 and is headquartered in Cambridge, the United Kingdom.
6
| Subsidiary | Biotechnology | 6 |
| Subsidiary | Miscellaneous Commercial Services | 5 | |
Capricorn Partners NV
 Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium.
5
| Private Company | Investment Managers | 5 |
| Public Company | Pharmaceuticals: Major | 5 | |
Oxford Asymmetry International Plc
4
| Extinct | Chemicals: Specialty | 4 |
Oxford Drug Design Ltd.
 Oxford Drug Design Ltd. Packaged SoftwareTechnology Services Oxford Drug Design Ltd. develops application of new technologies to drive computer-aided drug discovery. It specializes in drug discovery, molecular modeling, lead identification and optimisation, formulation modeling and preclinical studies. The company was founded by W. Graham Richards in 2001 and is headquartered in Oxford, the United Kingdom.
1
| Holding Company | Packaged Software | 1 |
Evox Therapeutics Ltd.
 Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom.
1
| Holding Company | Biotechnology | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Edwin Moses
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree | |
Avantium Technologies BV
 Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer Chief Executive Officer Director/Board Member General Counsel Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
deVGen NV
 deVGen NV BiotechnologyHealth Technology deVGen NV provides biotechnology services for the pharmaceutical and agrochemical industries. It innovates in crop protection research and environment induced stress tolerance for its own crops and provides technology to corporate partners. The firm produces and sells its hybrid seeds in field crops such as rice, sunflower, sorghum and pearl millet in the Indian subcontinent and Southeast Asia. The company was founded by Thierry Bogaert on September 10, 1997 and is headquartered in Ghent, Belgium. | Biotechnology | Founder Director of Finance/CFO Chairman | |
| BIOTALYS NV | Chemicals: Agricultural | Director of Finance/CFO Director/Board Member Director/Board Member | |
| University College London | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Anagenex, Inc.
 Anagenex, Inc. Packaged SoftwareTechnology Services Anagenex, Inc. is a company that uses high quality, large-scale data generation and AI to discover the next generation of small molecule medicines. Anagenex is based in San Francisco, CA. The company's platform leverages AI to design and synthesize hundreds of millions of target-specific compounds for testing in two weeks. The company's pipeline is focused on synthetic lethal oncology. The company was founded by Nicolas Tilmans and he has been the CEO since incorporation. | Packaged Software | Private Equity Investor Director/Board Member Director/Board Member | |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member Director/Board Member | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Chief Executive Officer Private Equity Investor Private Equity Investor | |
| VALERIO THERAPEUTICS | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Chief Executive Officer Corporate Officer/Principal Comptroller/Controller/Auditor | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
| Katholieke Universiteit Leuven | College/University | Graduate Degree Doctorate Degree | |
Inato SAS
 Inato SAS Information Technology ServicesTechnology Services Inato SAS develops platform that helps life science companies accelerate recruitment in their clinical trials by making data-informed decisions. The company was founded by Kourosh Davarpanah and William Pambrun and is headquartered in Paris, France. | Information Technology Services | Director/Board Member Director/Board Member | |
Heptares Therapeutics Ltd.
 Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Obvious Management Services LLC
 Obvious Management Services LLC Investment ManagersFinance Obvious Management Services LLC (Obvious Ventures) is a venture capital firm founded by EV Williams, James Joaquin and Vishal Vasishth in 2014. The firm headquartered in San Francisco, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Microphyt SA
 Microphyt SA BiotechnologyHealth Technology Microphyt SA researches, develops, produces and markets natural bioactive products from microalgae. Its solutions are intended to address the needs of personal-care, food and health-care industries worldwide, through a differentiated and sustainable approach and proprietary technologies allow controlled and industrial-scale supply of microalgae biomass and extracts. The firm''s Industrial scale photo bioreactors developed and patented and are designed to produce specific strains of microalgae by preserving cell integrity and yielding commercial quantities of slow-growing or biofilm-forming species. The company was founded by Arnaud Muller-Feuga in 2007 and is headquartered in Baillargues, France. | Biotechnology | Director/Board Member Director/Board Member | |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Consultant / Advisor Corporate Officer/Principal | |
Novavax AB
 Novavax AB Pharmaceuticals: GenericHealth Technology Novavax AB is engaged in research and development of vaccines. Its products include Matrix and AbiSCO. The company was founded by Bror Morein in 1999 and is headquartered in Uppsala, Sweden. | Pharmaceuticals: Generic | Chief Executive Officer Director/Board Member | |
| BIOCARTIS GROUP NV | Medical Specialties | Chief Executive Officer Chief Operating Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ORPHAZYME A/S | Pharmaceuticals: Major | Chairman Director/Board Member | |
Lux Capital Group LLC
 Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
| London Business School | College/University | Undergraduate Degree Human Resources Officer | |
| Imperial College London | College/University | Doctorate Degree Graduate Degree | |
Enveda Therapeutics, Inc.
 Enveda Therapeutics, Inc. BiotechnologyHealth Technology Enveda Therapeutics, Inc. is a biotechnology company based in Boulder, CO. The company has developed a drug discovery search engine that utilizes metabolomics and machine learning to create a high-resolution chemical map of the natural world. Enveda's team includes experienced drug hunters and data scientists who work together to tackle the toughest problems in drug discovery. The company was founded by Viswa Colluru and Pieter Dorrestein, with Viswa Colluru serving as CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
| OREXO AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SCHRÖDINGER, INC. | Packaged Software | Chief Executive Officer Director/Board Member | |
| The University of Reading | College/University | Doctorate Degree Undergraduate Degree | |
ArchiMed SAS
 ArchiMed SAS Investment ManagersFinance ArchiMed SAS (ArchiMed) is a private equity firm founded in 2014 by Cedric Berger, David Piccoli, and Vincent Guillaumot. The firm is headquartered in Lyon, France. | Investment Managers | Private Equity Analyst Founder | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Doctorate Degree | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Operating Officer | |
| Université Libre de Bruxelles | College/University | Undergraduate Degree Doctorate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Glaxo Group Research Ltd. | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | ||
Dimension Management LP
 Dimension Management LP Investment ManagersFinance Dimension Management LP is based in New York, NY. Dimension Management LP is a company that partners with founders at the intersection of technology and life sciences. The company was founded by Adam Goulburn, Zavain Dar, Nan Li. | Investment Managers | Founder Founder | |
Innovation Endeavors LLC
 Innovation Endeavors LLC Investment ManagersFinance Innovation Endeavors LLC (Innovation Endeavors) is a venture capital firm founded in 2010 by Dror Berman and Eric E. Schmidt. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 17 |
| Vereinigte Staaten | 14 |
| Frankreich | 7 |
| Belgien | 6 |
| Schweden | 4 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 13 |
| Finance | 8 |
| Commercial Services | 5 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 426 |
| Corporate Officer/Principal | 124 |
| Independent Dir/Board Member | 116 |
| Chairman | 114 |
| Private Equity Investor | 72 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Bo Jesper Hansen | 34 |
| Martin Murphy | 33 |
| Russell Greig | 31 |
| Nan Li | 29 |
| Catherine Moukheibir | 29 |
| Denis Lucquin | 26 |
| Alastair Riddell | 24 |
| Mats Gunnar Pettersson | 23 |
| Patrick J. Langlois | 23 |
| Geert Cauwenbergh | 22 |
| Stephen William Bunting | 22 |
| Remi Vermeiren | 22 |
| Zavain Dar | 21 |
| Peter John Fellner | 21 |
| William John Jenkins | 20 |
- Börse
- Insiders
- Edwin Moses
- Unternehmensverbindungen
